Royalty Pharma plc

NasdaqGS:RPRX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💰 Investment Banking & Asset Management

💊 Pharmaceuticals

💼 Private Equity

💰 Venture Capital

Location

United States

Market Cap

USD 21.58 B

Share Price

USD 37.58

Avg Daily Volume

4,310,611

Change (1 day)

1.54%

Change (1 year)

43.71%

Change (YTD)

47.32%

Royalty Pharma plc Accounts Payable for the year ending August 11, 2025: N/A

Royalty Pharma plc Accounts Payable is NA for the year ending August 11, 2025. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Competitors

Investor AB (publ)

USD 29.95

INVE-B.ST

+0.08 0.27%

SBI Holdings, Inc.

USD 43.16

8473.T

+1.15 2.75%

BB Biotech AG

USD 38.95

BION.SW

-0.15 -0.40%

Eli Lilly and Company

USD 625.65

LLY

-15.21 -2.37%

AbbVie Inc.

USD 198.05

ABBV

-0.81 -0.41%

Roche Holding AG

USD 318.77

RO.SW

-3.47 -1.08%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Abbott Laboratories

USD 134.28

ABT

+2.22 1.68%

Novartis AG

USD 116.31

NOVN.SW

+1.16 1.00%

Novo Nordisk A/S

USD 50.40

NOVO-B.CO

+2.25 4.67%

Merck & Co., Inc.

USD 80.69

MRK

+0.32 0.40%

Thermo Fisher Scientific Inc.

USD 460.72

TMO

+5.98 1.31%

Amgen Inc.

USD 288.23

AMGN

+3.53 1.24%

Pfizer Inc.

USD 24.58

PFE

+0.35 1.44%

Gilead Sciences, Inc.

USD 119.41

GILD

+9.13 8.28%

View all

Key Data

Date	Accounts Payable	Short-Term Debt	Long-Term Debt	Total Liabilities